“Dupilumab Improves Symptoms of Anxiety and Depression in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Three Phase 3 Trials (LIBERTY AD SOLO 1 and 2 and ADOL)”. 2020. SKIN The Journal of Cutaneous Medicine 4 (5): s48. https://doi.org/10.25251/skin.4.supp.47.